MedPath

Communities Fighting COVID-19!

Not Applicable
Completed
Conditions
Covid19
Interventions
Other: COVID-19 Testing Home-based (Aim 1)
Other: COVID-19 Testing Mobile Approach 2 (Aim 2)
Other: COVID-19 Testing Mobile (Aim 1)
Other: COVID-19 Testing Mobile Approach 1 (Aim 2)
Registration Number
NCT05148936
Lead Sponsor
San Diego State University
Brief Summary

To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.

Detailed Description

Communities Fighting COVID is a partnership between San Diego State's School of Public Health and numerous communities in San Diego focused on providing community-based testing to specific language-speaking communities and vulnerable populations. This partnership is funded by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics-Undeserved Populations (Radx-UP), with the aim of ensuring all Americans have access to timely COVID-19 testing and diagnosis. Many communities, particularly immigrant and people of color communities, have a harder time accessing existing COVID-19 resources due to transportation, language barriers, or other barriers.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32750
Inclusion Criteria
  • African American, Arabic speaking, Filipino, and Latino/a populations
Exclusion Criteria
  • Younger than 6, not in focus populations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
At home testing (Aim 1)COVID-19 Testing Home-based (Aim 1)High-risk friends and family of contacts exposed to COVID-19 will be provided with COVID-19 testing provided at home by a healthcare worker.
Mobile testing approach 2 (Aim 2)COVID-19 Testing Mobile Approach 2 (Aim 2)Mobile testing utilizing baseline outreach approaches
Mobile testing (Aim 1)COVID-19 Testing Mobile (Aim 1)High-risk friends and family of contacts exposed to COVID-19 will be referred to study operated mobile testing sites in the community for COVID-19 testing.
Mobile testing approach 1 (Aim 2)COVID-19 Testing Mobile Approach 1 (Aim 2)Mobile testing utilizing active outreach
Primary Outcome Measures
NameTimeMethod
Test uptakeThrough study completion, expected to be 20 months

Testing volume by study arm as cumulative count per hours testing site operated

Secondary Outcome Measures
NameTimeMethod
Test Impact (COVID-19 diagnoses)Through study completion, expected to be 20 months

Proportion of COVID-19 diagnoses of those tested by study arm

Test accessThrough study completion, expected to be 20 months

Proportion of individuals by study arm who note that this strategy has facilitated ability to test.

Test Impact (number needed to screen)Through study completion, expected to be 20 months

Number needed to screen (number tested in order to detect one new infection).

Trial Locations

Locations (1)

Contact Households

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath